Drawing on examples from real-world regulatory and clinical shifts across Asia, the US, Europe, and Australia, variables like regulation, AI, and gene editing are converging to redefine competitiveness in CGT. Read the full article to unpack what this means for the future of medicine, and how you can join the conversation at ISCT 2026.
Read More